Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11549791rdf:typepubmed:Citationlld:pubmed
pubmed-article:11549791lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:11549791lifeskim:mentionsumls-concept:C0011615lld:lifeskim
pubmed-article:11549791lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:11549791pubmed:issue1lld:pubmed
pubmed-article:11549791pubmed:dateCreated2001-9-10lld:pubmed
pubmed-article:11549791pubmed:abstractTextThis paper details a UK consensus conference held in London in April 2000 to establish guidelines for the use of cyclosporin A for atopic dermatitis in children. It should be reserved for the severest refractory atopic dermatitis. In view of its potential toxicity, careful monitoring is mandatory, in particular blood pressure and renal function.lld:pubmed
pubmed-article:11549791pubmed:languageenglld:pubmed
pubmed-article:11549791pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11549791pubmed:citationSubsetIMlld:pubmed
pubmed-article:11549791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11549791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11549791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11549791pubmed:statusMEDLINElld:pubmed
pubmed-article:11549791pubmed:issn1018-8665lld:pubmed
pubmed-article:11549791pubmed:authorpubmed-author:O'SullivanDDlld:pubmed
pubmed-article:11549791pubmed:authorpubmed-author:DillonM JMJlld:pubmed
pubmed-article:11549791pubmed:authorpubmed-author:HarperJ IJIlld:pubmed
pubmed-article:11549791pubmed:authorpubmed-author:FinlayA YAYlld:pubmed
pubmed-article:11549791pubmed:authorpubmed-author:HoldenC ACAlld:pubmed
pubmed-article:11549791pubmed:authorpubmed-author:CampR DRDlld:pubmed
pubmed-article:11549791pubmed:authorpubmed-author:Berth-JonesJJlld:pubmed
pubmed-article:11549791pubmed:authorpubmed-author:VeysP APAlld:pubmed
pubmed-article:11549791pubmed:copyrightInfoCopyright 2001 S. Karger AG, Basellld:pubmed
pubmed-article:11549791pubmed:issnTypePrintlld:pubmed
pubmed-article:11549791pubmed:volume203lld:pubmed
pubmed-article:11549791pubmed:ownerNLMlld:pubmed
pubmed-article:11549791pubmed:authorsCompleteYlld:pubmed
pubmed-article:11549791pubmed:pagination3-6lld:pubmed
pubmed-article:11549791pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11549791pubmed:meshHeadingpubmed-meshheading:11549791...lld:pubmed
pubmed-article:11549791pubmed:meshHeadingpubmed-meshheading:11549791...lld:pubmed
pubmed-article:11549791pubmed:meshHeadingpubmed-meshheading:11549791...lld:pubmed
pubmed-article:11549791pubmed:meshHeadingpubmed-meshheading:11549791...lld:pubmed
pubmed-article:11549791pubmed:meshHeadingpubmed-meshheading:11549791...lld:pubmed
pubmed-article:11549791pubmed:meshHeadingpubmed-meshheading:11549791...lld:pubmed
pubmed-article:11549791pubmed:meshHeadingpubmed-meshheading:11549791...lld:pubmed
pubmed-article:11549791pubmed:year2001lld:pubmed
pubmed-article:11549791pubmed:articleTitleCyclosporin for atopic dermatitis in children.lld:pubmed
pubmed-article:11549791pubmed:affiliationDepartment of Paediatric Dermatology, Great Ormond Street Hospital for Children, London, UK.lld:pubmed
pubmed-article:11549791pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11549791pubmed:publicationTypeGuidelinelld:pubmed
pubmed-article:11549791pubmed:publicationTypeReviewlld:pubmed
pubmed-article:11549791pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:11549791pubmed:publicationTypePractice Guidelinelld:pubmed
pubmed-article:11549791pubmed:publicationTypeConsensus Development Conferencelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11549791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11549791lld:pubmed